name

李永松

sex

age

84 岁

hospital number

902149

height

cm

weight

kg

BSA

1.96 m2

APACHEⅡ

19 分

Infection source

date

2017/11/25 年/月/日

Sequential Organ Failure Assessment

18 分

Fluid resuscitation

age>=60

septic shock

mechanical ventilation

Early fluid resuscitation

age<60

Pregnant woman

advanced malignant tumor

Pulmonary interstitial fibrosis

Serious arrhythmia

Small Tidal Volume Ventilation

Liver failure

Refuse to participate

Heart disease

美罗培南针 1.0g ivgtt q8h

vasoactive agent

120 min

150 min

300 min

Temperature

36.3 ℃

Heart Rate

85 次/分

Breath

18 次/分

Systolic pressure (SP)

110 mmHg

Diastolic pressure

56 mmHg

mean arterial pressure

75 mmHg

Pcv-aCO2

7.3 mmHg

DO2

581.1

VO2

143.3

Ca-vO2

45.1

pH value

7.45

PaO2

63.5 mmHg

PaCO2

30 mmHg

BE

-2.1 mmol/L(±2.3mmol/L)

SaO2

93.3 %

Blood lactic acid concentration, LAC

3.6 mmol/L

Oxygenation index (PaO2/FiO2)

79.4 mmHg

pH value

7.41

PcvO2

39.9 mmHg

PcvCO2

37.3 mmHg

BE

-0.9 mmol/L

ScvO2

70.3 %

Volume of input

0 ml

Volume of output

0 ml

Volume of urine

0 ml

ultrafiltration volume

0 ml

norepinephrine

Norepinephrine Dosage

0.25 μg/Kg/min

dopamine

Dopamine Dosage

μg/Kg/min

Dobutamine

Dobutamine Dosage

μg/Kg/min

CVP

7 mmHg

cardiac output

3.18 L/min

cardiac index

1.62 L/min/m2

stroke volume

43 ml

Stroke Index

19.1 ml/m2

ITBVI

824 ml/m2

GEDVI

659 ml/m2

EVLWI

19.5 ml/kg

PVPI

1.1

SVRI

3351 DSm2/cm5

CFI

3

GEF

12 %

SVV

7 %

PPV

%

dPmax

893

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

the number of B line

12 条

LUS

16 分

B+ Zone

区

IVC(inspiratory phase)

19 mm

IVC(expiratory phase)

18 mm

respiratory variations of inferior vena cavae diameter

5 %

15 mm

13 mm

12 mm

10 mm

IVC(inspiratory phase)

21 mm

IVC(expiratory phase)

18 mm

Respiratory variations of inferior vena cavae diameter

14 %

18 mm

15 mm

16 mm

12 mm

Temperature

16.4 ℃

Heart Rate

76 次/分

Breath

19 次/分

Systolic Pressure

130 mmHg

Diastolic Pressure

66 mmHg

Mean Arterial Pressure

89 mmHg

Pcv-aCO2

7.3 mmHg

DO2

591.4

VO2

132.1

Ca-vO2

40.3

PH value

7.44

PaO2

62.7 mmHg

PaCO2

31.3 mmHg

BE

-1.3 mmol/L

SaO2

92.7 %

Blood Lactic Acid Concentration

3.5 mmol/L

Oxygenation index (PaO2/FiO2)

78.4 mmHg

PH value

7.41

PcvO2

40.8 mmHg

PcvCO2

38.6 mmHg

BE

-0.2 mmol/L

ScvO2

72 %

Volume of input

1050 ml

Volume of output

200 ml

Volume of urine

200 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

5 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

5 mg

Levosimendan

CVP

7 mmHg

cardiac output

3.28 L/min

cardiac index

1.67 L/min/m2

stroke volume

31 ml

Stroke Index

22 ml/m2

ITBVI

948 ml/m2

GEDVI

759 ml/m2

EVLWI

10.5 ml/kg

PVPI

2.2

SVRI

3918 DSm2/cm5

CFI

2

GEF

12 %

SVV

5 %

PPV

%

dPmax

821

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

10 条

LUS

12 分

B+ Zone

区

Temperature

36.4 ℃

Heart Rate

82 次/分

Breath

19 次/分

Systolic Pressure

147 mmHg

Diastolic Pressure

70 mmHg

Mean Arterial Pressure

98 mmHg

Pcv-aCO2

7.9 mmHg

DO2

777.1

VO2

202.9

Ca-vO2

48.7

PH value

7.43

PaO2

89.7 mmHg

PaCO2

39.6 mmHg

BE

1.9 mmol/L

SaO2

97.8 %

Blood Lactic Acid Concentration

2.0 mmol/L

Oxygenation index (PaO2/FiO2)

149.5 mmHg

PH value

7.39

PcvO2

40.1 mmHg

PcvCO2

47.5 mmHg

BE

2.7 mmol/L

ScvO2

72.3 %

Volume of input

2100 ml

Volume of output

560 ml

Volume of urine

500 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

12 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

10 mg

Levosimendan

CVP

4 mmHg

cardiac output

4.17 L/min

cardiac index

2.13 L/min/m2

stroke volume

42 ml

Stroke Index

25.9 ml/m2

ITBVI

854 ml/m2

GEDVI

684 ml/m2

EVLWI

10.5 ml/kg

PVPI

2.5

SVRI

3533 DSm2/cm5

CFI

3

GEF

15 %

SVV

5 %

PPV

%

dPmax

996

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

8 条

LUS

10 分

B+ Zone

区

IVC(inspiratory phase)

17 mm

IVC(expiratory phase)

12 mm

Respiratory variations of inferior vena cavae diameter

29 %

15 mm

13 mm

13 mm

11 mm

Temperature

37.1 ℃

Heart Rate

72 次/分

Breath

18 次/分

Systolic Pressure

160 mmHg

Diastolic Pressure

77 mmHg

Mean Arterial Pressure

110 mmHg

Pcv-aCO2

6.8 mmHg

DO2

716.0

VO2

403.5

Ca-vO2

100.1

PH value

7.49

PaO2

67.5 mmHg

PaCO2

35.4 mmHg

BE

3.9 mmol/L

SaO2

94.6 %

Blood Lactic Acid Concentration

1.2 mmol/L

Oxygenation index (PaO2/FiO2)

112.5 mmHg

PH value

7.48

PcvO2

24.7 mmHg

PcvCO2

42.2 mmHg

BE

7.3 mmol/L

ScvO2

41.3 %

Volume of input

2860 ml

Volume of output

1020 ml

Volume of urine

960 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

25 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

30 mg

Levosimendan

CVP

9 mmHg

cardiac output

4.03 L/min

cardiac index

2.36 L/min/m2

stroke volume

48 ml

Stroke Index

22.8 ml/m2

ITBVI

1091 ml/m2

GEDVI

823 ml/m2

EVLWI

10.4 ml/kg

PVPI

1.9

SVRI

3419 DSm2/cm5

CFI

3

GEF

15 %

SVV

18 %

PPV

%

dPmax

753

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

5 条

LUS

8 分

B+ Zone

区

IVC(inspiratory phase)

18 mm

IVC(expiratory phase)

16 mm

Respiratory variations of inferior vena cavae diameter

11 %

15 mm

13 mm

12 mm

10 mm

Temperature

37 ℃

Heart Rate

110 次/分

Breath

20 次/分

Systolic Pressure

125 mmHg

Diastolic Pressure

70 mmHg

Mean Arterial Pressure

91 mmHg

Pcv-aCO2

10.5 mmHg

DO2

998.5

VO2

398.9

Ca-vO2

71.5

PH value

7.46

PaO2

68 mmHg

PaCO2

41.6 mmHg

BE

5.5 mmol/L

SaO2

94.6 %

Blood Lactic Acid Concentration

2.0 mmol/L

Oxygenation index (PaO2/FiO2)

170 mmHg

PH value

7.45

PcvO2

41.2 mmHg

PcvCO2

52.1 mmHg

BE

4.5 mmol/L

ScvO2

56.8 %

Volume of input

3700 ml

Volume of output

2180 ml

Volume of urine

2060 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

48 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

60 mg

Levosimendan

CVP

5 mmHg

cardiac output

5.58 L/min

cardiac index

2.85 L/min/m2

stroke volume

50 ml

Stroke Index

25.9 ml/m2

ITBVI

1151 ml/m2

GEDVI

921 ml/m2

EVLWI

10.9 ml/kg

PVPI

1.9

SVRI

2415 DSm2/cm5

CFI

3

GEF

11 %

SVV

24 %

PPV

%

dPmax

595

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

3 条

LUS

6 分

B+ Zone

区

IVC(inspiratory phase)

17 mm

IVC(expiratory phase)

15 mm

Respiratory variations of inferior vena cavae diameter

12 %

16 mm

14 mm

15 mm

12 mm

Temperature

36.9 ℃

Heart Rate

62 次/分

Breath

19 次/分

Systolic Pressure

117 mmHg

Diastolic Pressure

59 mmHg

Mean Arterial Pressure

81 mmHg

Pcv-aCO2

8.4 mmHg

DO2

671.5

VO2

147.0

Ca-vO2

37.4

PH value

7.47

PaO2

60.7 mmHg

PaCO2

42.3 mmHg

BE

6.7 mmol/L

SaO2

92.3 %

Blood Lactic Acid Concentration

2.2 mmol/L

Oxygenation index (PaO2/FiO2)

151.8 mmHg

PH value

7.46

PcvO2

39.9 mmHg

PcvCO2

50.7 mmHg

BE

5.6 mmol/L

ScvO2

72.1 %

Volume of input

4800 ml

Volume of output

3750 ml

Volume of urine

3500 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

52 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

80 mg

Levosimendan

CVP

6 mmHg

cardiac output

3.93 L/min

cardiac index

2.01 L/min/m2

stroke volume

37 ml

Stroke Index

32.3 ml/m2

ITBVI

1042 ml/m2

GEDVI

834 ml/m2

EVLWI

7.4 ml/kg

PVPI

1.4

SVRI

2991 DSm2/cm5

CFI

2

GEF

14 %

SVV

8 %

PPV

%

dPmax

5.8

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

2 条

LUS

5 分

B+ Zone

区

IVC(expiratory phase)

16 mm

Respiratory variations of inferior vena cavae diameter

15 %

IVC(inspiratory phase)

6 mm

15 mm

13 mm

13 mm

10 mm

NT-proBNP

1113 pg/ml

BNP

pg/ml

cTNI

0.602 ng/ml

Creatine kinase isoenzyme, CKMB

59 U/L

Creatinine

93 umol/L

Urea nitrogen

5.7 mmol/l

MDRD

ml/min/1.73m2

Date of examination

yyyy-mm-dd

WBC

20.1 X10*9/L

neutrophilic granulocyte percentage

92.3 %

Hb

146 g/L

CRP

24.31 mg/L

Procalcitonin, PCT

ng/ml

Date of test

Sequential Organ Failure Assessment

18 分

NT-proBNP

pg/ml

BNP

2771 pg/ml

cTNI

0.203 ng/ml

Creatine kinase isoenzyme, CKMB

8 U/L

Creatinine

87 umol/L

Urea nitrogen

13.3 mmol/l

MDRD

ml/min/1.73m2

WBC

20.7 X10*9/L

neutrophilic granulocyte percentage

94.7 %

Hb

140 g/L

CRP

303.67 mg/L

Procalcitonin, PCT

ng/ml

Sequential Organ Failure Assessment

15 分

NT-proBNP

602 pg/ml

BNP

pg/ml

cTNI

0.01 ng/ml

Creatine kinase isoenzyme, CKMB

9 U/L

Creatinine

69 umol/L

Urea nitrogen

14.1 mmol/L

MDRD

ml/min/1.73m2

WBC

13.9 X10*9/L

neutrophilic granulocyte percentage

92.7 %

Hb

141 g/L

CRP

250.5 mg/L

Procalcitonin, PCT

ng/ml

Sequential Organ Failure Assessment

10 分

Transfusion of Red Cells

Transfusion of Red Cells

U

Plasma infusion

Plasma infusion

ml

platelet transfusion

platelet transfusion

U

APACHEⅡ

10 分

Complication

prognosis

28-day mortality

survival time(day)

天

death time

yyyy/mm/dd

diagnosis of death

length of stay

29 天

duration in ICU

10 天

duration of mechanical ventilation

192 小时

ICU expenses

65020 元

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy

小时